Home » Topics » BioWorld Science

BioWorld Science
RSS

COX-2 inhibitors from Merck Frosst

June 9, 1997

Promising data with Parkinson's disease diagnostic reported

June 9, 1997

New antitumor agent from Teikoku Hormone characterized in mice

June 9, 1997

Encouraging phase II data with Connetics' ConXn reported

June 6, 1997

Phase III results with Lilly's raloxifene reported

June 6, 1997

Tolerance to benzodiazepine hypnotics overcome with melatonin

June 6, 1997

Selective tumor targeting reported for Bexxar

June 6, 1997

Target enrollment reached in phase III trial of Interferon's Alferon N Injection

June 6, 1997

COMT inhibitor increases response to L-DOPA in patients with PD

June 6, 1997

Alpha2-antagonist effective in patients with Parkinson's disease

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...